Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 53.60x is 75% below its 4-year average of 215.23x, near the low end of its 4-year range (2.70x–692.58x).
As of the fiscal period ended Thursday, June 30, 2022. 85.63% below its 12-month average of 373.09x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2022 (2022-06-30): 53.60x.
INTEREST COVERAGE RATIO
53.60x
INTEREST COVERAGE RATIO AVG TTM
373.09x
INTEREST COVERAGE RATIO AVG 3Y
373.09x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-85.63%
CURRENT VS 3Y AVG
-85.63%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+940.75%
vs the sector median at left
InMode Ltd.
Market Cap
$804.16M
Interest Coverage Ratio
53.60x
TTM Avg
373.09x
3Y Avg
373.09x
5Y Avg
N/A
Market Cap
$816.13M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$789.34M
Interest Coverage Ratio
N/A
TTM Avg
85.72x
3Y Avg
85.72x
5Y Avg
85.72x
Market Cap
$785.03M
Interest Coverage Ratio
1.76x
TTM Avg
1.92x
3Y Avg
1.86x
5Y Avg
1.93x
Market Cap
$828.48M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$778.01M
Interest Coverage Ratio
-0.78x
TTM Avg
1.83x
3Y Avg
1.88x
5Y Avg
1.58x
Market Cap
$777.34M
Interest Coverage Ratio
-5.87x
TTM Avg
6.84x
3Y Avg
6.84x
5Y Avg
3.53x
Market Cap
$776.24M
Interest Coverage Ratio
-1.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InMode Ltd. (INMD) | $804.16M | 53.60x | 373.09x | 373.09x | N/A |
| Jade Biosciences, Inc. (JBIO)vs › | $816.13M | N/A | N/A | N/A | N/A |
| Ardelyx, Inc. (ARDX)vs › | $817.67M | -1.44x | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $789.34M | N/A | 85.72x | 85.72x | 85.72x |
| AdaptHealth Corp. (AHCO)vs › | $785.03M | 1.76x | 1.92x | 1.86x | 1.93x |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $828.48M | N/A | N/A | N/A | N/A |
| Varex Imaging Corporation (VREX)vs › | $778.01M | -0.78x | 1.83x | 1.88x | 1.58x |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $777.34M | -5.87x | 6.84x | 6.84x | 3.53x |
| Geron Corporation (GERN)vs › | $776.24M | -1.65x | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $833.81M | N/A | N/A | N/A | N/A |
Interest Coverage
53.6x
Debt/Equity
0.01
Current Ratio
8.18
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2022-06-30 | 53.60x |
| 2021-09-30 | 692.58x |
| 2018-12-31 | 2.70x |
| 2018-06-30 | 112.04x |
